β-环糊精结构式
|
常用名 | β-环糊精 | 英文名 | β-cyclodextrin |
---|---|---|---|---|
CAS号 | 7585-39-9 | 分子量 | 1134.984 | |
密度 | 1.6±0.1 g/cm3 | 沸点 | 1541.2±60.0 °C at 760 mmHg | |
分子式 | C42H70O35 | 熔点 | >260ºC (dec.)(lit.) | |
MSDS | 中文版 美版 | 闪点 | 885.9±32.9 °C |
β-环糊精用途β-Cyclodextrin 是一种环状多糖,由 α-D-吡喃型葡萄糖单元通过 α-(1,4) 糖苷键连接而成。β-Cyclodextrin 通常用于增强药物的溶解度。 |
中文名 | β-环糊精 |
---|---|
英文名 | β-cyclodextrin |
中文别名 | beta-环糊精 | B-环糊精 | Beta-环状糊精 | β-环状糊精 | 倍他环糊精 | 环七糖 | 环麦芽七糖 |
英文别名 | 更多 |
描述 | β-Cyclodextrin 是一种环状多糖,由 α-D-吡喃型葡萄糖单元通过 α-(1,4) 糖苷键连接而成。β-Cyclodextrin 通常用于增强药物的溶解度。 |
---|---|
相关类别 | |
体外研究 | β-环糊精(β-环糊精;β-CD)是由α-(1,4)型键连接的七单位葡萄糖(α-D-吡喃葡萄糖)组成的环状多糖,具有亲水性外表面和疏水性内腔[1]。在制药工业中,β-环糊精(β-CD)经常被用于增强药物的溶解度,如吲哚美辛,柚皮苷,塞来昔布和柠檬酸[2]。 |
参考文献 |
密度 | 1.6±0.1 g/cm3 |
---|---|
沸点 | 1541.2±60.0 °C at 760 mmHg |
熔点 | >260ºC (dec.)(lit.) |
分子式 | C42H70O35 |
分子量 | 1134.984 |
闪点 | 885.9±32.9 °C |
精确质量 | 1134.369751 |
PSA | 554.05000 |
LogP | -6.57 |
外观性状 | 白色粉末 |
蒸汽压 | 0.0±0.6 mmHg at 25°C |
折射率 | 1.591 |
储存条件 | +15C to +30C |
水溶解性 | 1 M NaOH: 50 mg/mL |
更多 | 一、物性数据 1. 性状:白色至淡黄色粉末,稍有果胶特有香气,味微甜且略带酸味。 2. 密度(g/mL,25/4℃):0.7 3. 相对蒸汽密度(g/mL,空气=1):不确定 4. 熔点(ºC):116 5. 沸点(ºC,0.67kpa或5 mmHg):不确定 6. 折射率:不确定 7. 闪点(ºC):不确定 8. 比旋光度(ºC):不确定 9. 自燃点或引燃温度(ºC)不确定 10. 蒸气压(kPa,25ºC):不确定 11. 饱和蒸气压(kPa,60ºC):不确定 12. 燃烧热(KJ/mol):不确定 13. 临界温度(ºC):不确定 14. 临界压力(KPa):不确定 15. 油水(辛醇/水)分配系数的对数值:不确定 16. 爆炸上限(%,V/V):不确定 17. 爆炸下限(%,V/V):不确定 18. 溶解性:能溶于水,不溶于乙醇和其他有机溶剂。 |
β-环糊精上游产品 8 | |
---|---|
β-环糊精下游产品 8 | |
一般从柑橘皮、苹果皮、葡萄皮、蚕砂和甜菜渣等植物细胞中用酸解法、酶解法和离子交换法提取。
海关编码 | 3505100000 |
---|
β-cyclodextrin and curcumin, a potent cocktail for disaggregating and/or inhibiting amyloids: a case study with α-synuclein.
Biochemistry 53(25) , 4081-3, (2014) Aggregation of α-synuclein has been implicated in Parkinson's disease (PD). While many compounds are known to inhibit α-synuclein aggregation, dissolution of aggregates into their constituent monomers... |
|
CDDP supramolecular micelles fabricated from adamantine terminated mPEG and β-cyclodextrin based seven-armed poly (L-glutamic acid)/CDDP complexes.
Colloids Surf. B Biointerfaces 105 , 31-6, (2013) This research is aimed to develop a nano-sized supramolecular micelle delivery system of cis-dichlorodiammine platinum (II) (CDDP) in order to achieve the passive tumor targeting. Firstly, star-shaped... |
|
Characterization of the hydrochlorothiazide: β-cyclodextrin inclusion complex. Experimental and theoretical methods.
J. Phys. Chem. B 117(1) , 206-17, (2013) Hydrochlorothiazide (HCT) is one of the most commonly prescribed antihypertensive drugs. In an attempt to gain an insight into the physicochemical and molecular aspects controlling the complex archite... |
FEMA 4028 |
cycloheptaamylose |
EINECS 231-493-2 |
Cycloglucans |
betadex |
CARAWAY |
Cycloheptaglucosan |
Cvclodextrin |
beta-Cyclodextrin hydrate |
Klep |
(1R,3S,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33S,35S,36S,37S,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-Heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19 ;,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2.2.2.2.2.2]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol |
beta-cycloamylose |
BW 7 |
CavaMax W 7 |
beta-cyclodextrin |
cyclomaltoheptaose |
Celdex N |